ImmunityBio Ownership | Who Owns ImmunityBio?
ImmunityBio Ownership Summary
ImmunityBio is owned by 14.87% institutional investors, 66.44% insiders, and 18.69% retail investors. Vanguard group is the largest institutional shareholder, holding 3.46% of IBRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.10% of its assets in ImmunityBio shares.
IBRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ImmunityBio | 14.87% | 66.44% | 18.69% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 32.78M | 3.46% | $64.90M |
| Blackrock funding, inc. /de | 25.60M | 2.70% | $50.69M |
| Blackrock | 11.42M | 1.70% | $72.19M |
| Jane street group | 14.22M | 1.50% | $28.16M |
| State street | 11.32M | 1.27% | $27.84M |
| Geode capital management | 7.92M | 0.84% | $15.68M |
| Heights capital management | 6.57M | 0.74% | $16.15M |
| Goldman sachs group | 6.15M | 0.65% | $12.18M |
| Woodline partners lp | 5.30M | 0.60% | $13.03M |
| Morgan stanley | 5.11M | 0.54% | $10.11M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Heights capital management | 6.57M | 4.43% | $16.15M |
| Kercheville advisors | 643.14K | 1.58% | $4.93M |
| Mfg wealth management | 175.35K | 1.12% | $1.34M |
| Winning points advisors | 722.37K | 0.54% | $509.00K |
| Sheets smith wealth management | 552.02K | 0.48% | $4.23M |
| Wealth effects | 118.35K | 0.32% | $907.75K |
| Collective family office | 152.51K | 0.26% | $1.17M |
| Verity asset management | 68.75K | 0.22% | $527.33K |
| Tang capital management | 2.33M | 0.22% | $5.74M |
| Tigeroak management | 72.37K | 0.17% | $555.06K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Heights capital management | 6.57M | 4.43% | 6.57M |
| Blackrock funding, inc. /de | 25.60M | 0.00% | 5.79M |
| Vanguard group | 32.78M | 0.00% | 5.12M |
| Goldman sachs group | 6.15M | 0.00% | 5.01M |
| State street | 11.32M | 0.00% | 3.70M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -7.76M |
| Cormorant asset management, lp | - | - | -3.00M |
| Citigroup | 110.51K | 0.00% | -2.27M |
| Octagon capital advisors lp | - | - | -1.72M |
| Perceptive advisors | - | - | -1.22M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Heights capital management | 6.57M | 4.43% | 6.57M | $16.15M |
| Squarepoint ops | 1.01M | 0.00% | 1.01M | $2.49M |
| Winning points advisors | 722.37K | 0.54% | 722.37K | $509.00K |
| Susquehanna portfolio strategies | 393.59K | 0.02% | 393.59K | $968.22K |
| Quadrature capital | 262.39K | 0.01% | 262.39K | $642.86K |
Sold Out
| Holder | Change |
|---|---|
| Dinuzzo private wealth | -3.00 |
| Hfm investment advisors | -4.00 |
| Investors research | -15.00 |
| Financial gravity asset management | -17.00 |
| True wealth design | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 199 | -27.11% | 140,741,730 | -1.64% | 14 | 5.73% | 97 | -28.68% | 42 | -27.59% |
| Sep 30, 2025 | 181 | -26.42% | 94,869,384 | -19.91% | 10 | 6.01% | 85 | -45.51% | 42 | 23.53% |
| Jun 30, 2025 | 254 | 15.45% | 123,819,651 | 52.36% | 13 | 15.36% | 159 | 32.50% | 37 | -13.95% |
| Mar 31, 2025 | 220 | 4.27% | 81,251,228 | -1.72% | 9 | 6.75% | 119 | 6.25% | 44 | - |
| Dec 31, 2024 | 120 | -36.84% | 47,071,266 | -31.49% | 6 | 6.94% | 60 | -27.71% | 25 | -40.48% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 11.35M | 1.10% | -306.38K |
| State Street® SPDR® S&P® Biotech ETF | 10.24M | 0.99% | 154.25K |
| Vanguard Small Cap Index | 8.30M | 0.80% | 473.30K |
| iShares Russell 2000 ETF | 7.16M | 0.69% | -58.42K |
| Vanguard US Total Market Shares ETF | 5.72M | 0.67% | 1.43M |
| Vanguard Small Cap Growth Index Inv | 4.64M | 0.45% | 299.31K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.41M | 0.33% | 85.18K |
| SPDR® S&P Biotech ETF | 3.08M | 0.33% | 6.87K |
| Fidelity Small Cap Index | 2.86M | 0.28% | -33.56K |
| iShares Biotechnology ETF | 2.58M | 0.25% | 5.35K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 24, 2026 | Simon Barry J. | - | Sell | $900.79K |
| Feb 23, 2026 | Selecky Christobel | - | Sell | $250.00K |
| Feb 23, 2026 | Simon Barry J. | - | Sell | $1.69M |
| Feb 20, 2026 | Simon Barry J. | - | Sell | $92.50K |
| Jan 20, 2026 | Simon Barry J. | - | Sell | $503.36K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 8 |
| 2025 Q4 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
IBRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools